Cargando…
Data on the association of serum glypican-4 with future major adverse cardiovascular events and mortality in patients undergoing coronary angiography
This data article is associated to the research article titled ‘Serum glypican-4 is a marker of future vascular risk and mortality in coronary angiography patients' (Muendlein et al., 2022). The present article provides additional prospective data on the association of serum glypican-4 (GPC4) w...
Autores principales: | Muendlein, Axel, Brandtner, Eva Maria, Leiherer, Andreas, Geiger, Kathrin, Heinzle, Christine, Gaenger, Stella, Fraunberger, Peter, Mader, Arthur, Saely, Christoph H., Drexel, Heinz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046629/ https://www.ncbi.nlm.nih.gov/pubmed/35496482 http://dx.doi.org/10.1016/j.dib.2022.108142 |
Ejemplares similares
-
Evaluation of the association of serum glypican-4 with prevalent and future kidney function
por: Muendlein, Axel, et al.
Publicado: (2022) -
Data on the association between CTRP1 and future major adverse cardiovascular events in patients undergoing coronary angiography
por: Muendlein, Axel, et al.
Publicado: (2019) -
Coronary Event Risk Test (CERT) as a Risk Predictor for the 10-Year Clinical Outcome of Patients with Peripheral Artery Disease
por: Leiherer, Andreas, et al.
Publicado: (2023) -
Data on the power of the creatinine to uromodulin ratio in serum to predict cardiovascular events in coronary patients
por: Leiherer, Andreas, et al.
Publicado: (2017) -
Are SGLT2 polymorphisms linked to diabetes mellitus and cardiovascular disease? Prospective study and meta-analysis
por: Drexel, Heinz, et al.
Publicado: (2019)